US biopharma firm Questcor has signed a deal to acquire Canadian active pharmaceutical ingredient (API) manufacturer BioVectra for an upfront …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

